Niche Biologics AB Biosciences focuses on antibody-based biologics for diagnostic and therapeutic applications in immuno-oncology, presenting opportunities to position advanced research reagents and custom biologics to biotech labs and oncology-focused research groups.

Small Team Advantage With 2-10 employees, ABB can be a flexible partner for early-stage biotech startups and academic collaborators seeking specialized protein design and rapid prototyping capabilities.

R&D Platform Established platform for engineering therapeutic biologics and investigational immune-related protein reagents suggests potential for collaboration on target discovery, assay development, and profiling of novel immuno-oncology targets.

Funding Readiness Revenue in the lower-to-mid multi-million range and a long-standing history since 2007 indicate experienced leadership and potential for grant-driven programs, contract research, and sponsored development agreements.

Educational Outreach Active engagement with interns and a local Massachusetts ecosystem position ABB as a collaborative partner for university labs, training programs, and joint research initiatives that could expand project pipelines and grant-funded opportunities.